Literature DB >> 24085764

Robust ZFN-mediated genome editing in adult hemophilic mice.

Xavier M Anguela1, Rajiv Sharma, Yannick Doyon, Jeffrey C Miller, Hojun Li, Virginia Haurigot, Michelle E Rohde, Sunnie Y Wong, Robert J Davidson, Shangzhen Zhou, Philip D Gregory, Michael C Holmes, Katherine A High.   

Abstract

Monogenic diseases, including hemophilia, represent ideal targets for genome-editing approaches aimed at correcting a defective gene. Here we report that systemic adeno-associated virus (AAV) vector delivery of zinc finger nucleases (ZFNs) and corrective donor template to the predominantly quiescent livers of adult mice enables production of high levels of human factor IX in a murine model of hemophilia B. Further, we show that off-target cleavage can be substantially reduced while maintaining robust editing by using obligate heterodimeric ZFNs engineered to minimize unwanted cleavage attributable to homodimerization of the ZFNs. These results broaden the therapeutic potential of AAV/ZFN-mediated genome editing in the liver and could expand this strategy to other nonreplicating cell types.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085764      PMCID: PMC3821724          DOI: 10.1182/blood-2013-04-497354

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures.

Authors:  Yannick Doyon; Thuy D Vo; Matthew C Mendel; Shon G Greenberg; Jianbin Wang; Danny F Xia; Jeffrey C Miller; Fyodor D Urnov; Philip D Gregory; Michael C Holmes
Journal:  Nat Methods       Date:  2010-12-05       Impact factor: 28.547

Review 2.  Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.

Authors:  Mary Ellen Moynahan; Maria Jasin
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

3.  An unbiased genome-wide analysis of zinc-finger nuclease specificity.

Authors:  Richard Gabriel; Angelo Lombardo; Anne Arens; Jeffrey C Miller; Pietro Genovese; Christine Kaeppel; Ali Nowrouzi; Cynthia C Bartholomae; Jianbin Wang; Geoffrey Friedman; Michael C Holmes; Philip D Gregory; Hanno Glimm; Manfred Schmidt; Luigi Naldini; Christof von Kalle
Journal:  Nat Biotechnol       Date:  2011-08-07       Impact factor: 54.908

4.  A coagulation factor IX-deficient mouse model for human hemophilia B.

Authors:  H F Lin; N Maeda; O Smithies; D L Straight; D W Stafford
Journal:  Blood       Date:  1997-11-15       Impact factor: 22.113

5.  Vector characterization methods for quality control testing of recombinant adeno-associated viruses.

Authors:  J Fraser Wright; Olga Zelenaia
Journal:  Methods Mol Biol       Date:  2011

6.  High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency.

Authors:  E Ayuso; F Mingozzi; J Montane; X Leon; X M Anguela; V Haurigot; S A Edmonson; L Africa; S Zhou; K A High; F Bosch; J F Wright
Journal:  Gene Ther       Date:  2009-12-03       Impact factor: 5.250

7.  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.

Authors:  Elena E Perez; Jianbin Wang; Jeffrey C Miller; Yann Jouvenot; Kenneth A Kim; Olga Liu; Nathaniel Wang; Gary Lee; Victor V Bartsevich; Ya-Li Lee; Dmitry Y Guschin; Igor Rupniewski; Adam J Waite; Carmine Carpenito; Richard G Carroll; Jordan S Orange; Fyodor D Urnov; Edward J Rebar; Dale Ando; Philip D Gregory; James L Riley; Michael C Holmes; Carl H June
Journal:  Nat Biotechnol       Date:  2008-06-29       Impact factor: 54.908

8.  DNA-dependent PK inhibits adeno-associated virus DNA integration.

Authors:  Sihong Song; Yuanqing Lu; Young-Kook Choi; Yinong Han; Qiushi Tang; Ge Zhao; Kenneth I Berns; Terence R Flotte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

9.  Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver.

Authors:  Yasushi Magami; Takeshi Azuma; Hideto Inokuchi; Shinichiro Kokuno; Fuminori Moriyasu; Keiichi Kawai; Takanori Hattori
Journal:  Liver       Date:  2002-10

10.  In vivo genome editing restores haemostasis in a mouse model of haemophilia.

Authors:  Hojun Li; Virginia Haurigot; Yannick Doyon; Tianjian Li; Sunnie Y Wong; Anand S Bhagwat; Nirav Malani; Xavier M Anguela; Rajiv Sharma; Lacramiora Ivanciu; Samuel L Murphy; Jonathan D Finn; Fayaz R Khazi; Shangzhen Zhou; David E Paschon; Edward J Rebar; Frederic D Bushman; Philip D Gregory; Michael C Holmes; Katherine A High
Journal:  Nature       Date:  2011-06-26       Impact factor: 49.962

View more
  69 in total

1.  Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells.

Authors:  Jia Liu; Thomas Gaj; Yifeng Yang; Nan Wang; Sailan Shui; Sojung Kim; Chidananda Nagamangala Kanchiswamy; Jin-Soo Kim; Carlos F Barbas
Journal:  Nat Protoc       Date:  2015-10-22       Impact factor: 13.491

Review 2.  Current Progress in Therapeutic Gene Editing for Monogenic Diseases.

Authors:  Versha Prakash; Marc Moore; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2016-01-14       Impact factor: 11.454

3.  In Vivo Zinc Finger Nuclease-mediated Targeted Integration of a Glucose-6-phosphatase Transgene Promotes Survival in Mice With Glycogen Storage Disease Type IA.

Authors:  Dustin J Landau; Elizabeth Drake Brooks; Pablo Perez-Pinera; Hiruni Amarasekara; Adam Mefferd; Songtao Li; Andrew Bird; Charles A Gersbach; Dwight D Koeberl
Journal:  Mol Ther       Date:  2016-02-11       Impact factor: 11.454

Review 4.  Gene therapy for hemophilia: what does the future hold?

Authors:  Bhavya S Doshi; Valder R Arruda
Journal:  Ther Adv Hematol       Date:  2018-08-27

Review 5.  Viral vectors for therapy of neurologic diseases.

Authors:  Sourav R Choudhury; Eloise Hudry; Casey A Maguire; Miguel Sena-Esteves; Xandra O Breakefield; Paola Grandi
Journal:  Neuropharmacology       Date:  2016-02-21       Impact factor: 5.250

Review 6.  Genome editing and the next generation of antiviral therapy.

Authors:  Daniel Stone; Nixon Niyonzima; Keith R Jerome
Journal:  Hum Genet       Date:  2016-06-08       Impact factor: 4.132

7.  Hitting the target without pulling the trigger.

Authors:  Thierry VandenDriessche; Marinee K Chuah
Journal:  Mol Ther       Date:  2015-01       Impact factor: 11.454

Review 8.  Delivery technologies for genome editing.

Authors:  Hao Yin; Kevin J Kauffman; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2017-03-24       Impact factor: 84.694

Review 9.  Genome-Editing Technologies: Principles and Applications.

Authors:  Thomas Gaj; Shannon J Sirk; Sai-Lan Shui; Jia Liu
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

10.  Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break.

Authors:  Geoffrey L Rogers; Hsu-Yu Chen; Heidy Morales; Paula M Cannon
Journal:  Mol Ther       Date:  2019-09-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.